Search Within

Han Xiao

Formats
  1. Meeting Abstract (32)
  2. Journal Article (26)
  3. Book Section (1)
Groups
  1. Department of Medicine (59)
  2. Genitourinary Oncology Service (59)
  3. Solid Tumor Oncology Division (59)
  4. Epidemiology and Biostatistics (21)
  5. Survivorship Research (20)
  6. Biostatistics Service (16)

More Groups

People
  1. Eric Sherman (13)
  2. David Pfister (12)
  3. Matthew Fury (11)
  4. Sofia Haque (10)
  5. Alan Ho (9)
  6. Dean Bajorin (9)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (6)
  4. 2022 (5)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Annals of Oncology (5)
  3. Cancer (3)
  4. Head & Neck (2)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  6. Atlas of Genitourinary Oncological Imaging (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. Oxford University Press (6)
  3. Wiley Blackwell (3)
  4. American Association for Cancer Research (2)
  5. Elsevier Inc. (2)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (59)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Depth of PSA nadir and subsequent PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
    Meeting Abstract

    Aggarwal, R. R.; Dooley, K.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T. B.; Appleman, L. J.; Weckstein, D. J.; Patnaik, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Randomized phase III study of enzalutamide compared with enzalutamide plus abiraterone for metastatic castration-resistant prostate cancer (Alliance A031201 trial)
    Journal Article

    Morris, M. J.; Heller, G.; Hillman, D. W.; Bobek, O.; Ryan, C.; Antonarakis, E. S.; Bryce, A. H.; Hahn, O.; Beltran, H.; Armstrong, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Baseline characteristics associated with PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
    Meeting Abstract

    Aggarwal, R. R.; Heller, G.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T. B.; Appleman, L. J.; Weckstein, D. J.; Patnaik, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • PRESTO: A phase III, open-label study of androgen annihilation in patients (pts) with high-risk biochemically relapsed prostate cancer (AFT-19)
    Meeting Abstract

    Aggarwal, R.; Heller, G.; Hillman, D.; Xiao, H.; Picus, J.; Wang, J.; Taplin, M. E.; Dorff, T.; Appleman, L. J.; Weckstein, D.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of sacituzumab govitecan (SG) in patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) progressing on androgen receptor signaling inhibitors (ARSI)
    Meeting Abstract

    Lang, J.; Tagawa, S. T.; Slovin, S.; Emamekhoo, H.; Rathkopf, D.; Abida, W.; Autio, K.; Xiao, H.; Molina, A. M.; Eickhoff, J.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Goals of care documentation by medical oncologists and oncology patient end-of-life care outcomes
    Journal Article

    Epstein, A. S.; Riley, M.; Nelson, J. E.; Bernal, C.; Martin, S.; Xiao, H.
    Cancer (2022)

    Fulltext@MSK | Save
  • Acupuncture versus massage for pain in patients living with advanced cancer: A protocol for the IMPACT randomised clinical trial
    Journal Article

    Romero, S. A. D.; Emard, N.; Baser, R. E.; Panageas, K.; MacLeod, J.; Walker, D.; Barton-Burke, M.; Liou, K.; Deng, G.; Farrar, J.; more...
    BMJ Open (2022)

    Fulltext@MSK | Save
  • Dermatological adverse events in prostate cancer patients treated with the androgen receptor inhibitor apalutamide
    Journal Article

    Pan, A.; Reingold, R. E.; Zhao, J. L.; Moy, A.; Kraehenbuehl, L.; Dranitsaris, G.; McBride, S. M.; Scher, H. I.; Kollmeier, M. A.; Xiao, H.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Interim results of AASUR: A single arm, multi-center phase 2 trial of apalutamide (A) + abiraterone acetate + prednisone (AA plus P) + leuprolide with stereotactic ultra-hypofractionated radiation (UHRT) in very high risk (VHR), node negative (N0) prostate cancer (PCa)
    Meeting Abstract

    McBride, S. M.; Spratt, D. E.; Kollmeier, M.; Abida, W.; Xiao, H.; Slovin, S. F.; Paller, C. J.; Deville, C.; Den, R. B.; Hearn, J. W. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Documentation of goals of care (GOC) by medical oncologists is associated with improved oncology patient end-of-life (EOL) care outcomes
    Meeting Abstract

    Xiao, H.; Riley, M.; Donopria, R.; Martin, S.; Nelson, J. E.; Epstein, A. S.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save